The American Chemical Society honors scientists from Bristol-Myers Squibb for the contributions to the discovery of the combination of the pioneering hepatitis C virus (HCV) NS5A inhibitor, Daklinza® (daclatasvir), and the acylsulfonamide-containing HCV NS3 protease inhibitor, Sunvepra™ (asunaprevir), which together demonstrated for the first time that HCV infection could be cured with only direct-acting antiviral agents.

Awardees: Makonen Beleman, Min Gao, Andrew Good, Lawrence Hamann, Fiona McPhee, Nicholas Meanwell, Van Nguyen, Paul Scola, Lawrence Snyder, Li-Qiang Sun, Alan Xiangdong Wang.

Subscribe! [ Ссылка ]
Twitter! [ Ссылка ]

For more information, please visit the Heroes of Chemistry website: [ Ссылка ]
You might also like:

Prized Science:
[ Ссылка ]

Q&A with Dr. Valentine Ananikov:
[ Ссылка ]

ACS Catalysis Lectureship Award Video Series:
[ Ссылка ]

Produced by the American Chemical Society, the world’s largest scientific society. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences.

Join the American Chemical Society! [ Ссылка ]

свернуть